title: The interleukin-2 receptor: a target for immunotherapy.
authors.affiliation: Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
authors.forename: T A
authors.initials: TA
authors.lastname: Waldmann
authors.forename: C
authors.initials: C
authors.lastname: Goldman
authors.forename: L
authors.initials: L
authors.lastname: Top
authors.forename: A
authors.initials: A
authors.lastname: Grant
authors.forename: J
authors.initials: J
authors.lastname: Burton
authors.forename: R
authors.initials: R
authors.lastname: Bamford
authors.forename: E
authors.initials: E
authors.lastname: Roessler
authors.forename: I
authors.initials: I
authors.lastname: Horak
authors.forename: S
authors.initials: S
authors.lastname: Zaknoen
authors.forename: C
authors.initials: C
authors.lastname: Kasten-Sportes
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D015490:HTLV-I Infections / Q000276:immunology / Q000628:therapy; D006801:Humans; D007167:Immunotherapy; D000922:Immunotoxins / Q000627:therapeutic use; D015458:Leukemia, T-Cell / Q000276:immunology / Q000628:therapy; D009369:Neoplasms / Q000276:immunology; D015375:Receptors, Interleukin-2 / Q000032:analysis / Q000737:chemistry / Q000276:immunology / Q000502:physiology*
chemical_list: D000911:Antibodies, Monoclonal; D000922:Immunotoxins; D015375:Receptors, Interleukin-2